Expression of concern
Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer
Paper Information
Record ID:
45133
Author(s):
Publication Date:
January 01, 2019
Retraction Date:
December 28, 2022
(2.9 years years ago)
Subjects:
Institutions:
- Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
- The First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, China
- School of Nursing, Nanjing Medical University, Nanjing, Jiangsu, China
- School of Biomedical Engineering & Informatics, Nanjing Medical University, Nanjing, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
SAGE Publications
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1177/15330338221146361Citations (32)
32
Total Citations4
Post-Retraction(12.5%)
28
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
517
Days since retraction (latest)
LncRNA PART1 promotes malignant biological behaviours associated with head and neck cancer cells via synergistic action with FUT6
Yanheng Yao, Yuxin Zhang, Jiyuan Shi et al. (9 authors)
Cancer Cell International
Open Access
Published: May 2024
1 citation
1 citation
517 days after retraction
Urinary PART1 and PLA2R1 Could Potentially Serve as Diagnostic Markers for Diabetic Kidney Disease Patients
Qinglin Ye, Guiling Xu, Hao Yuan et al. (11 authors)
Diabetes Metabolic Syndrome and Obesity
Open Access
Published: Dec 2023
1 citation
1 citation
338 days after retraction
LncRNA PART1 promotes malignant biological behaviors associated with head and neck cancer cells by synergistic action with FUT6
Yanheng Yao, Jiyuan Shi, Yunran Gao et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Oct 2023
288 days after retraction
A review on the role of long non-coding RNA prostate androgen-regulated transcript 1 (PART1) in the etiology of different disorders
Soudeh Ghafouri‐Fard, Atefeh Harsij, Bashdar Mahmud Hussen et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Feb 2023
4 citations
4 citations
49 days after retraction
Long non‑coding RNA PART1: dual role in cancer
Rui Ran, Chaoyang Gong, Zhiqiang Wang et al. (8 authors)
Human Cell
Published: Jul 2022
12 citations
12 citations
160 days before retraction
Inconsistency in the expression pattern of a five-lncRNA signature as a potential diagnostic biomarker for gastric cancer patients in bioinformatics and in vitro.
Mahmoud Ghanei, Arash Poursheikhani, Azadeh Aarabi et al. (5 authors)
DOAJ (DOAJ: Directory of Open Access Journals)
Open Access
Published: Jun 2022
1 citation
1 citation
210 days before retraction
LncRNA ARAP1-AS1 Promotes Bladder Cancer Development by Regulating the miR-3918/KIF20A Axis
Wei Zhang, Jingyu Zhang, Zhi Hu et al. (8 authors)
Molecular Biotechnology
Published: May 2022
11 citations
11 citations
229 days before retraction
A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy
Dechao Feng, Xu Shi, Qiao Xiong et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Feb 2022
25 citations
25 citations
321 days before retraction
Biological functions and clinical significance of long noncoding RNAs in bladder cancer
Yan Zhang, Xianwu Chen, Juntao Lin et al. (4 authors)
Cell Death Discovery
Open Access
Published: Oct 2021
33 citations
33 citations
449 days before retraction
Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2
Jingyang Zhou, Jinhui Che, Lu Xu et al. (6 authors)
Digestive and Liver Disease
Published: Sep 2021
26 citations
26 citations
479 days before retraction
lncRNA LOC339524 inhibits the proliferation of bladder cancer cells by targeting the miR‑875‑5p/COPS7A signaling axis
Xuan He, He Xiao, Rui Yang et al. (5 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Aug 2021
4 citations
4 citations
492 days before retraction
Inconsistency in Expression Pattern of a Five-lncRNA Signature As a Potential Diagnostic Biomarker for Gastric Cancer Patients in Bioinformatics and in Vitro
Mahmoud Ghanei, Arash Poursheikhani, Azadeh Aarabi et al. (5 authors)
Research Square (Research Square)
Open Access
Published: Aug 2021
492 days before retraction
The Role of Tumor-related LncRNA PART1 in Cancer
Jinlan Chen, Enqing Meng, Yexiang Lin et al. (7 authors)
Current Pharmaceutical Design
Published: Jul 2021
2 citations
2 citations
540 days before retraction
Peer Review #2 of "Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma (v0.1)"
Jiaying Liang, Yaofeng Zhi, Wenhui Deng et al. (16 authors)
Unknown Journal
Open Access
Published: Jun 2021
565 days before retraction
Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
Jiaying Liang, Yaofeng Zhi, Wenhui Deng et al. (16 authors)
PeerJ
Open Access
Published: Jun 2021
35 citations
35 citations
565 days before retraction
Peer Review #3 of "Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma (v0.1)"
Jiaying Liang, Yaofeng Zhi, Wenhui Deng et al. (16 authors)
Unknown Journal
Open Access
Published: Jun 2021
565 days before retraction
Peer Review #1 of "Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma (v0.1)"
Jiaying Liang, Yaofeng Zhi, Wenhui Deng et al. (16 authors)
Unknown Journal
Open Access
Published: Jun 2021
565 days before retraction
LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p
Xiancheng Han, Jing Liu, Yongguo Liu et al. (5 authors)
Cancer Management and Research
Open Access
Published: May 2021
15 citations
15 citations
576 days before retraction
Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122
Xibao Hu, Lei Zhang, Jingjing Tian et al. (4 authors)
World Journal of Surgical Oncology
Open Access
Published: Apr 2021
16 citations
16 citations
620 days before retraction
LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation
Qiongqiong Yu, Yajing Du, Suping Wang et al. (4 authors)
The Journal of Biochemistry
Published: Mar 2021
12 citations
12 citations
656 days before retraction
Silencing LINC00482 inhibits tumor-associated inflammation and angiogenesis through down-regulation of MMP-15 via FOXA1 in bladder cancer
Yizhuo Wang, Ping Zhang, Na Wei et al. (6 authors)
Aging
Open Access
Published: Dec 2020
30 citations
30 citations
747 days before retraction
Downregulation of Long Noncoding RNA LUCAT1 Suppresses the Migration and Invasion of Bladder Cancer by Targeting miR-181c-5p
Yifan Chen, Wentao Zhang, Liliang Shen et al. (8 authors)
BioMed Research International
Open Access
Published: Nov 2020
10 citations
10 citations
771 days before retraction
<p>LncRNA PART1 Exerts Tumor-Suppressive Functions in Tongue Squamous Cell Carcinoma via miR-503-5p</p>
Xiqun Zhao, Yanqing Hong, Qingyuan Cheng et al. (4 authors)
OncoTargets and Therapy
Open Access
Published: Oct 2020
21 citations
21 citations
818 days before retraction
<p>Long Noncoding RNA <em>PART1</em> Promotes Hepatocellular Carcinoma Progression via Targeting miR-590-3p/<em>HMGB2</em> Axis</p>
Jian Pu, Chuan Tan, Zesheng Shao et al. (9 authors)
OncoTargets and Therapy
Open Access
Published: Sep 2020
23 citations
23 citations
848 days before retraction
PART1 and hsa-miR-429-Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients
Chengmin Xuan, Mingwei Jin, Lei Wang et al. (8 authors)
BioMed Research International
Open Access
Published: Apr 2020
13 citations
13 citations
989 days before retraction
<p>Long Non-Coding RNA PART1 Exerts Tumor Suppressive Functions in Glioma via Sponging miR-190a-3p and Inactivation of PTEN/AKT Pathway</p>
Zheng Gen Jin, Lianhua Piao, Guangchao Sun et al. (6 authors)
OncoTargets and Therapy
Open Access
Published: Feb 2020
37 citations
37 citations
1061 days before retraction
LncRNA PART1 facilitates the malignant progression of colorectal cancer via miR‐150‐5p/LRG1 axis
Tingting Lou, Kongliang Ke, Luqing Zhang et al. (5 authors)
Journal of Cellular Biochemistry
Published: Jan 2020
49 citations
49 citations
1090 days before retraction
Silencing of lncRNA PART1 inhibits proliferation, invasion and migration of breast cancer cells and promotes the efficacy of cisplatin in breast cancer cells
Li Zhang, Jie Zhang, Chuandou Ni
General Physiology and Biophysics
Open Access
Published: Jan 2020
7 citations
7 citations
1092 days before retraction
Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression
Deyao Wu, Tielong Zhang, Jie Wang et al. (6 authors)
Aging
Open Access
Published: Dec 2019
20 citations
20 citations
1107 days before retraction
Cancer‐associated fibroblasts–derived exosomes‐mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion
Lei Yan, Pei‐Yu Wang, Weihua Fang et al. (4 authors)
Cell Biochemistry and Function
Published: Nov 2019
54 citations
54 citations
1133 days before retraction
LncRNA PART1 regulates colorectal cancer via targeting miR-150-5p/miR-520h/CTNNB1 and activating Wnt/β-catenin pathway
Taicheng Zhou, Lili Wu, Ning Ma et al. (6 authors)
The International Journal of Biochemistry & Cell Biology
Published: Oct 2019
51 citations
51 citations
1161 days before retraction
Assessment of biochemical recurrence of prostate cancer (Review)
Xiaozeng Lin, Anil Kapoor, Yan Gu et al. (7 authors)
International Journal of Oncology
Open Access
Published: Oct 2019
27 citations
27 citations
1181 days before retraction
Quick Stats
Total Citations:
32
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025